The Impact of Nocturia on Mortality: A Systematic Review and Meta-Analysis.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 1 8 2019
medline: 24 3 2020
entrez: 1 8 2019
Statut: ppublish

Résumé

Nocturia (waking from sleep at night to void) is a common cause of sleep disruption associated with increased comorbidity and impaired quality of life. However, its impact on mortality remains unclear. We performed a systematic review and meta-analysis to evaluate the association of nocturia with mortality as a prognostic factor and a causal risk factor. We searched PubMed®, Scopus®, CINAHL® (Cumulative Index of Nursing and Allied Health Literature) and major conference abstracts up to December 31, 2018. Random effects meta-analyses were done to address the adjusted RR of mortality in people with nocturia. Meta-regression was performed to explore potential determinants of heterogeneity, including the risk of bias. We applied the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) framework to rate the quality of evidence for nocturia as a prognostic risk factor for mortality and separately as a cause of mortality. Of the 5,230 identified reports 11 observational studies proved eligible for inclusion. To assess nocturia 10 studies used symptom questionnaires and 1 used frequency-volume charts. Nocturia was defined as 2 or more episodes per night in 6 studies (55%) and as 3 or more episodes per night in 5 (45%). Pooled estimates demonstrated a RR of 1.27 (95% CI 1.16-1.40, I Nocturia is probably associated with an approximately 1.3-fold increased risk of death.

Identifiants

pubmed: 31364920
doi: 10.1097/JU.0000000000000463
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

486-495

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Jori S Pesonen (JS)

Department of Urology, Päijät-Häme Central Hospital, Lahti, Finland.
Department of Urology, Tampere University Hospital, Tampere, Finland.
Faculty of Medicine and Life Science, University of Tampere, Tampere, Finland.

Rufus Cartwright (R)

Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom.
Department of Urogynaecology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.

Robin W M Vernooij (RWM)

Department of Research, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.

Yoshitaka Aoki (Y)

Department of Urology, University of Fukui, Fukui, Japan.

Arnav Agarwal (A)

Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Altaf Mangera (A)

Department of Urology, Sheffield Teaching Hospitals, Sheffield, United Kingdom.

Alayne D Markland (AD)

Department of Medicine and Division of Gerontology, Geriatrics and Palliative Care, University of Alabama Birmingham School of Medicine, Birmingham, Alabama.
Department of Veterans Affairs, Birmingham/Atlanta Geriatric Research Education and Clinical Center, Atlanta, Georgia.

Johnson F Tsui (JF)

Department of Urology, Hackensack University Medical Center, New Jersey.

Henrikki Santti (H)

Department of Urology, University of Helsinki, Helsinki, Finland.
Helsinki University Hospital, Helsinki, Finland.

Tomas L Griebling (TL)

Department of Urology and The Landon Center On Aging, University of Kansas, Kansas City, Kansas.

Alexey E Pryalukhin (AE)

Department of Urology, North-Western State Medical University named after I. I. Mechnikov, Saint Petersburg, Russia.
Department of Pathology, University Hospital of Bonn, Bonn, Germany.

Jarno Riikonen (J)

Department of Urology, Tampere University Hospital, Tampere, Finland.
Faculty of Medicine and Life Science, University of Tampere, Tampere, Finland.

Riikka M Tähtinen (RM)

Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland.

Camille P Vaughan (CP)

Department of Veterans Affairs, Birmingham/Atlanta Geriatric Research Education and Clinical Center, Atlanta, Georgia.
Department of Medicine, Division of General Medicine and Geriatrics, Emory University School of Medicine, Atlanta, Georgia.

Theodor M Johnson (TM)

Department of Veterans Affairs, Birmingham/Atlanta Geriatric Research Education and Clinical Center, Atlanta, Georgia.
Department of Medicine, Division of General Medicine and Geriatrics, Emory University School of Medicine, Atlanta, Georgia.

Anssi Auvinen (A)

Faculty of Social Sciences, University of Tampere, Tampere, Finland.

Diane Heels-Ansdell (D)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.

Gordon H Guyatt (GH)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Department of Medicine, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.

Kari A O Tikkinen (KAO)

Department of Urology, University of Helsinki, Helsinki, Finland.
Helsinki University Hospital, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH